CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Dianthus Therapeutics Inc (DNTH) Financial Analysis | CapyFin

Dianthus Therapeutics Inc

DNTH · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reports earnings today

after market closes

Total operating expenses

Cash and Equivalents

Loading...

Key Statistics

Market Cap

$2.68B

P/E Ratio

-45.58

Sector

N/A

Industry

N/A

52-Week High

$65.2

52-Week Low

$36.1

R&D expenses

$59.9M

G&A expenses

$9.93M

Total operating expenses

$69.8M

Net loss per share

$1.43

Weighted avg shares

44.97M

Dianthus Therapeutics Inc

Dianthus Therapeutics Inc

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...